Durvalumab for MSI-H or POLE Mutated Metastatic Colorectal Cancer
Clinical trial NCT03435107 · COMPLETED
Trial details
- NCT number
- NCT03435107
- Sponsor
- Asan Medical Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-04-12
- Primary completion
- 2023-04-26
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.